Prognosis in pulmonary embolism

Current Opinion in Pulmonary Medicine

Volumn 7, Issue 5, 2001, Pages 354-359

  Douketis, James D ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

DISEASE COURSE; LUNG EMBOLISM; MEDICAL DECISION MAKING; POSTTHROMBOSIS SYNDROME; PROGNOSIS; PULMONARY HYPERTENSION; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0034815856     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200109000-00018     Document Type: Review

References (62)

1. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan
2. Strategy for diagnosis of patients with suspected acute pulmonary embolism
3. Iliofemoral phlebography in pulmonary embolism
4. Massive pulmonary embolism: Diagnostic and therapeutic strategies
5. The clinical course of pulmonary embolism
6. Clinical epidemiology of venous thromboembolic disease
7. The clinical course of patients with suspected pulmonary embolism
8. Echocardiography doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate
9. Recurrent pulmonary embolism: A prospective study
10. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: A prospective study
11. Recurrence of pulmonary embolism during anticoagulant treatment: A prospective study
12. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry
13. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
14. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
15. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
16. Long-term prognosis of treated acute massive pulmonary embolism
17. Medical compared with surgical treatment for massive pulmonary embolism
18. The incidence of pulmonary embolism in unexplained sudden cardiac arrest with pulseless electrical activity
19. Pulmonary embolism as cause of cardiac arrest
20. The long-term clinical course of acute deep vein thrombosis
21. Late sequelae of deep venous thrombosis: Follow-up of 278 patients after anticoagulant and thrombolytic therapy
22. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis: A prospective study
23. Venous thromboembolism
24. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: A population-based study
25. Postthrombotic syndrome after hip or knee arthroplasty
26. Chronic thromboembolic pulmonary hypertension
27. The clinical profile of unresolved pulmonary embolism
28. Chronic thrombosis of major pulmonary arteries
29. Pulmonary embolism: One-year follow-up with echocardiography doppler and five-year survival analysis
30. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
31. Predictors of recurrence after deep vein thrombosis and pulmonary embolism
32. Recurrent venous thromboembolism after deep vein thrombosis
33. Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism
34. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
35. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
36. Mortality in patients treated for pulmonary embolism
37. Predictors of survival after deep vein thrombosis and pulmonary embolism
38. Thirty-day case-fatality rates for pulmonary embolism in the elderly
39. Clinical characteristics of fatal pulmonary embolism in a referral hospital
40. Resistance to activated protein C in an unselected population of patients with pulmonary embolism
41. Inherited thrombophilic risk factors and venous thromboembolism: Distinct role in peripheral deep venous thrombosis and pulmonary embolism
42. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: A focus on the factor V Leiden mutation
43. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of Factor V Leiden or prothrombin G20210A
44. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
45. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population
46. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism
47. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism
48. Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis
49. Deep vein thrombosis and pulmonary embolism. A single disease entity with different risk factors?
50. Location and extent of deep vein thrombosis in patients with and without FV:R 506Q mutation
51. Need for long-term anticoagulant treatment of symptomatic calf-vein thrombosis
52. Factor V Leiden and fatal pulmonary embolism
53. Evaluation of role of factor V Leiden mutation in fatal pulmonary thromboembolism
54. Elevated cardiac troponins in patients with submassive pulmonary embolism
55. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction
56. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism
57. Troponine I dans l'embolie pulmonaire aigue massive: Resultats d'une serie prospective
58. The pathophysiology of failure in acute right ventricular hypertension: Hemodynamic and biochemical correlations
59. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism
60. Short-term outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
61. The epidemiology, pathogenesis, and natural history of venous thrombosis
62. Epidemiology and natural history of venous thromboembolism